BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.

Highlights Beijing Aosaikang Pharmaceutical Co., Ltd.

Equities

002755

CNE100001X92

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 04/07/2024 BST			5-day change	1st Jan Change
9.84 ^CNY	+7.78%		+1.97%	-9.06%

07-02	Beijing Aosaikang Pharmaceutical's Unit Gets Nod to Register Fosaprepitant Dimeglumine for Injection	MT
05-10	Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Beijing Aosaikang Pharmaceutical's Unit Gets Nod to Register Fosaprepitant Dimeglumine for Injection	07-02	MT
Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection	05-10	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection	03-05	MT
Aosaikang Pharmaceutical Registers Breast Cancer Drug	01-23	MT
Aosaikang Pharmaceutical's Unit Gets Nod for Two Drugs	01-17	MT
Aosaikang Pharmaceutical's Unit Gets Nod to Trial ASKC202 Tablets	11-13	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Aosaikang Pharmaceutical's Unit Gets Nod to Test Gastric Cancer Drug	17/10/23	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Aosaikang Pharma's Unit Gets Nod to Amend Instructions for Heart Drug	07/08/23	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Aosaikang Pharma Registers Three Drugs	24/03/23	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on June 20, 2022	10/06/22	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	23/05/22	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	05/05/22	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Beijing Aosaikang Pharmaceutical Co., Ltd.

Equities

002755

CNE100001X92

Highlights

Filters